跳到主要內容

Opaleye Management Inc. 的 Form 4 申報

Grace Therapeutics, Inc.GRCE,2026/10/16 申報

申報編號
0001493152-26-047473
申報時間
2026/10/16 20:42 ET
交易日
2026/10/14-10/16
申報延遲
2 天
10b5-1 計畫
沒有勾選

這份申報列了 3 筆非衍生性交易。公開市場買進合計 $13.6 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Opaleye Management Inc.CIK 0001595855持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/10/14Common Stock, par value $0.0001 per shareP買進取得+11,233$1.93F2+$21,734.732,884,522間接
2026/10/15Common Stock, par value $0.0001 per shareP買進取得+23,485$1.95F3+$45,685.372,908,007間接
2026/10/16Common Stock, par value $0.0001 per shareP買進取得+36,347$1.89F4+$68,757.622,944,354間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.90 to $1.98. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.

表 I 有 1 筆交易的價格引用這則附註。

F3

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.90 to $1.95. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.

表 I 有 1 筆交易的價格引用這則附註。

F4

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.89 to $1.90. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)